Resolute Rare Rash: A Case of Childhood Cutaneous Polyarteritis Nodosa - A Rare Vasculitis

Introduction: This case highlights the importance of early recognition and histopathologic confirmation of cutaneous polyarteritis nodosa (CPAN) to prevent progression to vaso-occlusive complications in children.

Background: Cutaneous polyarteritis nodosa (CPAN) is a rare, skin-limited necrotizing vasculitis involving small- to medium-sized arteries of the dermis and subcutaneous tissue without visceral involvement. It belongs to the spectrum of leukocytoclastic vasculitis and is distinguished from systemic polyarteritis nodosa by the absence of major organ disease. Childhood CPAN typically follows a chronic, relapsing–remitting course with generally favorable prognosis, although distal ischemic complications may occur. Diagnosis relies on clinicopathologic correlation and exclusion of systemic vasculitis.

Summary: We report a 10-year-old Filipino female who presented with an eight-week history of progressive, painful erythematous-to-violaceous macules and nodules over the lower extremities, later involving the hands, accompanied by edema, Raynaud-like changes, and difficulty ambulating. Initial assessments included muscle strain, cutaneous infection, and juvenile idiopathic arthritis. Laboratory evaluation revealed leukocytosis, thrombocytosis, markedly elevated inflammatory markers (ESR 93 mm/hr, CRP 72.3 mg/dL), and elevated antistreptolysin O titer, with negative antinuclear antibody and no evidence of systemic organ involvement. Imaging studies were unremarkable. Full-thickness skin biopsy demonstrated medium-vessel vasculitis with fibrinoid necrosis and inflammatory infiltrates, consistent with polyarteritis nodosa. After exclusion of infectious etiologies, systemic corticosteroid therapy (prednisone 2 mg/kg/day) was initiated, resulting in clinical improvement.

Learning Points: CPAN should be considered in children presenting with painful palpable purpura and nodules on the extremities, particularly when inflammatory markers are elevated and systemic involvement is absent. A comprehensive evaluation to exclude systemic vasculitis is essential. An early skin biopsy prior to steroid initiation confirms the diagnosis. Prompt anti-inflammatory and immunosuppressive therapy can prevent progression to ischemia and long-term complications, underscoring the importance of timely recognition and close follow-up in pediatric patients.